Confirmed Speakers: 

ALI, Syed – USA – Methamphetamine-induced Hyperthermia, Blood Brain Barrier Damage and Neurotoxicity • ANDERSEN, Julie – USA – Iron and Parkinson´s Disease • ASCHNER, Michael – USA – C. Elegans and the role of dopamine in Mn-induced neurotoxicity • CADET, Jean Lud – USA – Methamphetamine preconditioning, gene expression, and epigenetic changes in the rat striatum •CAVIEDES, Pablo – Chile – Neuronal cell line models in the study of  genetic regulatory circuits and cellular dysfunction in human Down syndrome: Possible therapeutic targets • CECCATELLI, Sandra – Sweden – Glucocorticoids induce long-lasting effects in neural stem cells resulting in senescence-related alterations •COLLINS, Michael – USA – Neuroinflammatory PLA2 mechanisms underlying binge alcohol-induced neurodegeneration: prevention by omega-3 fatty acid • CORY-SLECHTA, Debbie – USA – Stress as a Modifier of Lead-Induced Neurotoxicity: Cumulative Risk • DANYSZ, Wojciech and PARSONS, C.G. – Germany  – Memantine as a treatment of Alzheimer´s disease – current status of preclinical data •ELISABETSKY, Elaine – Brazil -Could dirty drugs be useful to clean the mess? The role of natural products in neurodegenerative diseases • FERREIRA, Sergio – Brazil – Impact of soluble Abeta oligomers on plasticity-related receptors and mechanisms of synapse failure in Alzheimer's disease • GHISO, Jorge – USA – Matrix metalloproteases modulate Aβ toxicity in cells compromised by cerebral amyloid angiopathy • GUILLEMIN, Gilles – Australia – Kynurenine pathway, Neuroinflammation and Neurodegeneration • HARRY, Jean– USA – Age related effects of IL-1 and IL-6 on injury-induced hippocampal neurogenesis • HERRERA-MARSCHITZ, Mario – Chile -Plasticity of the CNS following metabolic insults occurring at birth: sentinel proteins as novel therapeutic targets  • HERRERO, María Trinidad – Spain – Does genetic and environmental interaction in the glucocorticoid receptor increase vulnerability to PD? • INESTROSA, Nibaldo – Chile – Roles of Wnt Signaling in the Central Nervous System KOSTRZEWA, Richard – USA – Beyond L-DOPA Therapy of Parkinson’s Disease • LEVINE, Harry – USA – Neuropathology, Aβ Conformation, and Neurotoxicity •MOCCHETTI, Italo – USA – Chemokines in neurotoxicity and neuroprotection • MORATALLA, Rosario – Spain – Molecular mechanisms involved in the neurotoxicity induced by methamphetamine and MDMA in the striatum • NORENBERG, Michael – USA – Ammonia and glutamine as mitochondrial toxins ONAIVI, Emmanuel – USA – From cannabinoid genomics to medical marijuana • OTEIZA, Patricia – USA – Role of zinc in the developing brain • PREDIGER, Rui – Brazil and RAISMAN-VOZARI, Rita – France – The intranasal MPTP model of Parkinson's disease: new insights for an old toxin • REGLODI, Dora – Hungary – Endogenous protection from stressors: insights from PACAP knockout mice • ROSTAGNO, Agueda – USA – Vasculotropic Aβ genetic variants and the activation of mitochondrial apoptotic pathways • SEGURA AGUILAR, Juan – Chile -Cytoskeleton disruption during  dopamine oxidative metabolism in substantia nigra derived cells and autophagy neuroprotection • SKOWROŃSKA, Marta – Poland – Modulation of ammonia-induced oxidative/nitrosative stress in cultured rat brain endothelial cells.• SPANAKI, Cleanthe – Greece – Role of GDH in ammonia homeostasis • TASKER, Andrew –  Canada – Progressive changes in hippocampal structure and function following low-dose neonatal domoic acid • TIZABI, Yousef  – USA – Some Pharmacological Insights on the Good and Bad of Alcohol and Nicotine • VON BERNHARDI, Rommy– Chile – The effect of aging on the brain’s defense mechanisms: a new edge on the participation of glia on neurodegenerative diseases • WAAGEPETERSEN, Helle – Denmark – Ammonia neurotoxicity and role of alanine as an ammonia scavenger • WALKER, Lary – USA – Prion-Like Seeding of Cerebral Aβ Deposition in Transgenic Rodents • ZHOU, Xin-Fu – Australia – Role of p75NTR in the toxicity and endocytosis of Abeta